HOYA (7741) Q4 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2026 earnings summary
30 Apr, 2026Executive summary
Consolidated revenue and operating profit reached historical highs in Q4 FY25, driven by strong demand in the Information Technology business and robust Life Care segment performance.
Full-year revenue rose 9.4% to ¥947.7 billion, with profit before tax up 26% to ¥327.7 billion and net profit attributable to owners up 25.2% to ¥253.1 billion.
Both Life Care and Information Technology segments contributed to growth, with advanced semiconductor products and health care/medical products performing strongly.
Cash and cash equivalents increased to ¥574.1 billion at year-end, and annual dividends per share rose to ¥295.
Financial highlights
Q4 FY25 revenue: ¥248.1bn, up 15% year-over-year (CC +9%); Q4 operating profit: ¥74.7bn, up 14% (CC +10%); Q4 pretax profit: ¥77.6bn, up 15%.
Q4 basic EPS: ¥160.80, up from ¥149.53 a year earlier.
Q4 operating cash flow: ¥79.7bn; free cash flow: ¥65.8bn.
Full-year FY25 revenue: ¥947.7bn, up 9% (CC +8%); operating profit: ¥285.2bn, up 12% (CC +11%); pretax profit: ¥327.7bn, up 26% (CC +26%).
Full-year operating cash flow: ¥278.4bn; free cash flow: ¥270.9bn.
Outlook and guidance
FY26 targets stable growth in eyeglass lenses via high-value-added products and expansion in progressive lenses.
Plans to expand sales of ATIOLS and stabilize supply in IOLS segment.
Focus on expanding high-value-added masks in FPD and non-digital camera segments in Imaging.
Continued investment in production capacity for EUV blanks and HDD substrates.
Management expects continued growth, supported by strong demand in both Life Care and Information Technology segments, but notes risks from currency fluctuations and global economic conditions.
Latest events from HOYA
- Record Q3 profit and revenue growth fueled by strong segments and one-time gains.7741
Q3 20266 Feb 2026 - Record revenue, profit, and cash flow, with robust shareholder returns and ESG progress.7741
Q2 202631 Oct 2025 - Record revenue and profit growth, driven by Life Care and IT, with a strong outlook ahead.7741
Q1 20261 Aug 2025 - Information Technology drove double-digit profit growth despite Life Care's IT challenges.7741
Q1 202513 Jun 2025 - Information Technology drove double-digit revenue growth, offsetting Life Care's medical challenges.7741
Q2 202513 Jun 2025 - Record revenue growth, higher dividend, and strong IT offset by Q4 FX losses.7741
Q4 20256 Jun 2025 - Q3 profit before tax surged 31.3% on IT strength; full-year outlook remains strong.7741
Q3 20255 Jun 2025